Price Jennifer C. Amarin Corp Plcuk Transaction History

Price Jennifer C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.85 - $1.43 $136,000 - $228,800	160,000 Added 7.21%	2,380,000 $2.19 Million
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.49 $118,910 - $158,193	106,170 Added 5.02%	2,220,000 $2.64 Million
Q1 2023 May 12, 2023	BUY	$1.19 - $2.19 $135,457 - $249,287	113,830 Added 5.69%	2,113,830 $3.17 Million
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $525,905 - $658,610	491,500 Added 32.58%	2,000,000 $2.42 Million
Q2 2022 Aug 15, 2022	BUY	$1.13 - $3.69 $1.7 Million - $5.57 Million	1,508,500 New	1,508,500 $2.25 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Price Jennifer C., based on Form 13F filings with the SEC.

Stay updated on Price Jennifer C. with notifications on news.